1. Home
  2. CASY vs NTRA Comparison

CASY vs NTRA Comparison

Compare CASY & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casey's General Stores Inc.

CASY

Casey's General Stores Inc.

HOLD

Current Price

$658.17

Market Cap

24.5B

Sector

Miscellaneous

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$195.86

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASY
NTRA
Founded
1959
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical Specialities
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
28.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CASY
NTRA
Price
$658.17
$195.86
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$667.18
$259.07
AVG Volume (30 Days)
374.7K
1.1M
Earning Date
03-09-2026
05-07-2026
Dividend Yield
0.34%
N/A
EPS Growth
9.01
0.65
EPS
14.79
N/A
Revenue
$15,940,899,000.00
$210,939,000.00
Revenue This Year
$10.63
$16.65
Revenue Next Year
$5.36
$19.22
P/E Ratio
$44.95
N/A
Revenue Growth
7.25
N/A
52 Week Low
$397.80
$125.38
52 Week High
$694.93
$256.36

Technical Indicators

Market Signals
Indicator
CASY
NTRA
Relative Strength Index (RSI) 47.56 42.80
Support Level $540.43 $194.03
Resistance Level $684.33 $251.09
Average True Range (ATR) 20.56 7.64
MACD -3.69 0.76
Stochastic Oscillator 45.27 40.07

Price Performance

Historical Comparison
CASY
NTRA

About CASY Casey's General Stores Inc.

Casey's General Stores Inc serves as convenience store chain with its 2,900 locations, positioned in the Midwest United States. About half of Casey's stores are located in rural towns with populations under 5,000. While fueling stations serve as a key traffic driver, about two-thirds of the company's gross profit stems from in-store sales of grocery items, prepared meals, and general merchandise. Casey's owns more than 90% of its stores and operates the majority of its warehousing and distribution processes internally.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: